| GlaxoSmithKline AG - Fluarix Tetra 15 mcg / 0.5 ml, Injektionssuspension | | 62961 | | 01 | | Fluarix Tetra 15 mcg / 0.5 ml | | Injektionssuspension | | J07BB02 | | Influenza, Inactivated, Split Virus Or Surface Antigen | | 28.05.2014 | | |
| | Composition | | haemagglutininum influenzae A (H1N1) Virus Stamm A/California/7/2009 (H1N1)-like: reassortant virus NIB-74xp derived from A/Christchurch/16/2010 15 µg, haemagglutininum influenzae A (H3N2) Virus Stamm A/Texas/50/2012 (H3N2)-like: reassortant virus NYMC X-223A 15 µg, haemagglutininum influenzae B Virus Stamm B/Massachusetts/02/2012-like: reassortant virus NYMC BX-51B (Yamagata lineage) 15 µg, haemagglutininum influenzae B Virus Stamm B/Brisbane/60/2008 (Victoria lineage) 15 µg, polysorbatum 80, octoxinolum-10, natrii chloridum, magnesii chloridum hexahydricum, dinatrii phosphas dodecahydricus, kalii dihydrogenophosphas, kalii chloridum, alfa-tocopheroli hydrogenosuccinas, aqua ad iniectabilia q.s. ad suspensionem pro 0.5 ml. | | Packungsbestandteile | | Injection suspension | | | | | | Active Agent | Dose |
|---|
| | 15 µg | | | 15 µg |
|
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| No entries have been found. |
|
|
